Generic Zantac Recalled Due to Nitrosodimethylamine NDMA
Recalls of Heartburn Drugs Raise Alarm Over Impurities in Medications Sold in the U.S. NEW YORK, N.Y. — The U.S. Food and Drug Administration (FDA) sought removal of Zantac and generic forms of Zantac because the active ingredient in those drugs — ranitidine — has the potential to produce a contaminant that is highly suspected … [Read more...]
Zantac NDMA Recall
USA- Health.harvard.edu writes that the recall of the commonly used heartburn medication, Zantac, has been expanded. The recall of Zantac, which is the brand name for ranitidine, was originally reported to the FDA by Valisure, an online pharmacy. Valisure had found that the medication had what they referred to as “extremely high … [Read more...]
Generic Zantac Cancer
WASHINGTON, D.C. — The U.S. Food and Drug Administration will work with drug manufacturing companies to recall generic versions of Zantac because of the presence of a potentially cancer-causing agent located in the medication. The U.S. FDA said that potentially cancer-causing agent in Zantac is n-nitrosodimethylamine or NDMA for … [Read more...]
